ROYAL BANK OF CANADA - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 42 filers reported holding PLX PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PLX PHARMA INC
ValueSharesWeighting
Q3 2022$0
-100.0%
2450.0%0.00%
Q2 2022$1,000
-99.1%
245
-99.1%
0.00%
Q1 2022$116,000
-37.3%
28,702
+24.2%
0.00%
Q4 2021$185,000
-31.7%
23,107
+64.4%
0.00%
Q3 2021$271,000
+135.7%
14,057
+69.3%
0.00%
Q2 2021$115,0008,305
+16510.0%
0.00%
Q1 2021$050
+4900.0%
0.00%
Q3 2020$01
-98.6%
0.00%
Q2 2020$0730.0%0.00%
Q1 2020$073
+265.0%
0.00%
Q4 2019$020
-63.0%
0.00%
Q3 2019$054
+5300.0%
0.00%
Q2 2018$010.0%0.00%
Q1 2018$010.0%0.00%
Q4 2017$010.0%0.00%
Q3 2017$010.00%
Other shareholders
PLX PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 1,875,000$4,556,0000.28%
Ground Swell Capital, LLC 48,931$119,0000.22%
Park West Asset Management LLC 1,473,218$3,580,0000.20%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$152,0000.07%
Eidelman Virant Capital 27,000$63,0000.04%
MBL Wealth, LLC 52,000$1260.03%
O'Brien Greene & Co. Inc 22,340$54,0000.02%
SHUFRO ROSE & CO LLC 56,800$138,0000.01%
GW&K Investment Management, LLC 424,921$1,033,0000.01%
EXANE DERIVATIVES 6,575$15,974,0000.01%
View complete list of PLX PHARMA INC shareholders